Cetuximab Alternatives Compared
| Cetuximab Remove Cetuximab from your drug comparison | Erbitux Remove Erbitux from your drug comparison | Keytruda Remove Keytruda from your drug comparison |
|---|
| Cetuximab Remove Cetuximab from your drug comparison | Erbitux cetuximab Remove Erbitux from your drug comparison | Keytruda pembrolizumab Remove Keytruda from your drug comparison | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescribed for Head and Neck Cancer, Squamous Cell Carcinoma, Colorectal Cancer. May also be prescribed off label for Non-Small Cell Lung Cancer, Pancreatic Cancer. |
Prescribed for Head and Neck Cancer, Squamous Cell Carcinoma, Colorectal Cancer. Erbitux may also be used for purposes not listed in this medication guide. |
Keytruda is a type of immunotherapy that helps boost the immune system's response against cancer. It may be used to treat many different types of cancer in adults and children and is given by... View more |
||||||||||||||||
|
Prescription only |
Prescription only |
Prescription only |
||||||||||||||||
Ratings & Reviews |
||||||||||||||||||
Drug Class |
||||||||||||||||||
Side Effects |
||||||||||||||||||
|
See the full cetuximab side effects document. |
See the full Erbitux side effects document. |
See the full Keytruda side effects document. |
||||||||||||||||
Pricing and Coupons* Prices are without insurance |
||||||||||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Erbitux prices |
View all Keytruda prices |
||||||||||||||||
Generic Availability |
||||||||||||||||||
|
No |
No |
No |
||||||||||||||||
Dosage Form(s) Available |
||||||||||||||||||
| N/A |
|
|
||||||||||||||||
Brand Names |
||||||||||||||||||
| Erbitux |
N/A |
N/A |
||||||||||||||||
Half LifeThe half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. |
||||||||||||||||||
|
213 hours |
213 hours |
624 hours |
||||||||||||||||
CSA Schedule**View glossary of terms. |
||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category |
||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
Category D
Positive evidence of risk
See the full Pregnancy Warnings document. |
||||||||||||||||
Drug Interactions |
||||||||||||||||||
|
A total of 19 drugs are known to interact with cetuximab:
|
A total of 19 drugs are known to interact with Erbitux:
|
A total of 13 drugs are known to interact with Keytruda:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions |
||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Disease Interactions |
||||||||||||||||||
First Approval Date |
||||||||||||||||||
|
N/A |
February 12, 2004 |
N/A |
||||||||||||||||
WADA ClassView World Anti-Doping Agency classifications. |
||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
More Information |
||||||||||||||||||
Consumer Resources |
||||||||||||||||||
Professional Resources |
||||||||||||||||||
Related Treatment Guide |
||||||||||||||||||
|
||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.